These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1687576)

  • 1. Depression and topical ophthalmic beta adrenergic blockade.
    Bourgeois JA
    J Am Optom Assoc; 1991 May; 62(5):403-6. PubMed ID: 1687576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse effects of local use of beta-blockaders in glaucoma. A literature review and a survey of reports to the adverse drug reaction authority 1986-95].
    Nygaard HA; Høvding G
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2019-21. PubMed ID: 9235677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current use of ophthalmic beta blockers.
    Gross RL; Pineyro A
    J Glaucoma; 1997 Jun; 6(3):188-91. PubMed ID: 9211143
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topical optical beta-adrenergic antagonists and quinidine--a risky combination].
    Pianka P; Lazar M; Geyer O
    Harefuah; 1998 Mar; 134(5):402-3. PubMed ID: 10909562
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
    Good CB
    Pharmacoepidemiol Drug Saf; 2001; 10(6):509-10. PubMed ID: 11828832
    [No Abstract]   [Full Text] [Related]  

  • 6. Glaucoma medication during pregnancy and nursing.
    Coppens G; Stalmans I; Zeyen T
    Bull Soc Belge Ophtalmol; 2010; (314):33-6. PubMed ID: 20480749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic drug interactions with topical glaucoma medications.
    Gerber SL; Cantor LB; Brater DC
    Surv Ophthalmol; 1990; 35(3):205-18. PubMed ID: 1980380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic effects of topical beta-blocker therapy: the family physician's role.
    White GL; Crandall AS; Harrow J; Goodenough G
    J Fam Pract; 1991 Jan; 32(1):99-101. PubMed ID: 1670641
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic effects of topical ophthalmic medications.
    Selvin BL
    South Med J; 1983 Mar; 76(3):349-58. PubMed ID: 6131541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of glaucoma medications.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peyronie's disease following long-term use of topical timolol.
    Ross JJ; Rahman I; Walters RF
    Eye (Lond); 2006 Aug; 20(8):974-6. PubMed ID: 16151480
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-prescribing of medications used to treat obstructive lung disease, congestive heart failure and depression among users of topical beta blockers: estimates from three US Veterans Affairs Medical Centers.
    Valuck RJ; Perlman JI; Anderson C; Wortman GI
    Pharmacoepidemiol Drug Saf; 2001; 10(6):511-6. PubMed ID: 11828833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cardiovascular benefit of ophthalmic beta-blockade.
    Easton PJ
    Age Ageing; 2007 May; 36(3):351. PubMed ID: 17405778
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety of topical beta-blockers in glaucoma treatment.
    Goldberg I
    Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of topical ophthalmic beta-adrenoceptor antagonists.
    Rait JL
    Aust N Z J Ophthalmol; 1999 Feb; 27(1):57-64. PubMed ID: 10080340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
    Taniguchi T; Kitazawa Y
    Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New aspects on systemic adverse effects of ocular drugs].
    Uusitalo H; Salminen L
    Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504
    [No Abstract]   [Full Text] [Related]  

  • 18. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
    Patane' S; Marte F; Di Bella G; Pugliatti P
    Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal respiratory arrest following timolol ophthalmic solution.
    Malnick SD; Gelzer G; Attali M
    MedGenMed; 2001 Mar; 3(2):12. PubMed ID: 11549961
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact dermatitis due to levobunolol in eyedrops.
    Garcia F; Blanco J; Juste S; Garces MM; Alonso L; Marcos ML; Carretero P; Perez R
    Contact Dermatitis; 1997 Apr; 36(4):230. PubMed ID: 9165213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.